4.7 Article

Human CD38 regulates B cell antigen receptor dynamic organization in normal and malignant B cells

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Cell Biology

The calcium signaling enzyme CD38-a paradigm for membrane topology defining distinct protein functions

Hon Cheung Lee et al.

Summary: CD38 is a key enzyme with multiple enzymatic activities on the cell membrane, playing different roles inside and outside the cell. It catalyzes the synthesis of two nucleotide second messengers and has two opposite membrane orientations. Research shows that CD38 is involved in mobilizing endoplasmic Ca2+ stores, as well as playing a role in cell adhesion and lymphocyte activation.

CELL CALCIUM (2022)

Article Hematology

Molecular dynamics of targeting CD38 in multiple myeloma

Fabio Malavasi et al.

Summary: This study explored the multiple functions of CD38 and the effects of therapeutic antibodies on membrane dynamics and gene expression in multiple myeloma cells. The exposure to anti-CD38 antibodies resulted in changes in metabolism-related and cell cycle-related genes, as well as modulation of microRNA expression. Microvesicles released from the antibody-exposed cells showed alterations in both protein expression and microRNA levels, suggesting a potential role in intercellular signaling and immune response modulation. The findings provide insights on the potential mechanisms for enhancing the efficacy of anti-CD38 therapeutic antibodies.

BRITISH JOURNAL OF HAEMATOLOGY (2021)

Review Cell Biology

Evolving concepts in NAD+ metabolism

Claudia C. S. Chini et al.

Summary: NAD and NADP have diverse roles beyond co-factors in oxidation-reduction reactions, including signaling pathways, post-translational modifications, epigenetic changes, and RNA regulation. Recent studies have shown that NAD metabolism is highly dynamic with a short halflife in some tissues, and new concepts are emerging in the roles of NAD pathway metabolites in various disease states. Resolving open questions in NAD biology will lead to significant advancements in the field.

CELL METABOLISM (2021)

Article Biochemistry & Molecular Biology

Continuous signaling of CD79b and CD19 is required for the fitness of Burkitt lymphoma B cells

Xiaocui He et al.

EMBO JOURNAL (2018)

Review Oncology

Daratumumab: a first-in-class CD38 monoclonal antibody for the treatment of multiple myeloma

Larysa Sanchez et al.

JOURNAL OF HEMATOLOGY & ONCOLOGY (2016)

Article Public, Environmental & Occupational Health

Global burden of cancers attributable to infections in 2012: a synthetic analysis

Martyn Plummer et al.

LANCET GLOBAL HEALTH (2016)

Article Biochemistry & Molecular Biology

The nanoscale organization of the B lymphocyte membrane

Palash Chandra Maity et al.

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2015)

Editorial Material Pharmacology & Pharmacy

Daratumumab granted breakthrough drug status

Jacob P. Laubach et al.

EXPERT OPINION ON INVESTIGATIONAL DRUGS (2014)

Article Hematology

Immunophenotyping in multiple myeloma and related plasma cell disorders

Shaji Kumar et al.

BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY (2010)

Article Multidisciplinary Sciences

Chronic active B-cell-receptor signalling in diffuse large B-cell lymphoma

R. Eric Davis et al.

NATURE (2010)

Review Oncology

Mechanisms of B-cell lymphoma pathogenesis

R Küppers

NATURE REVIEWS CANCER (2005)

Review Cell Biology

The RAF proteins take centre stage

C Wellbrock et al.

NATURE REVIEWS MOLECULAR CELL BIOLOGY (2004)